Ivermectin Could Be a ‘Powerful Drug’ for Fighting Cancer, Here’s Why

quote:

---

The first reports of ivermectin’s anti-cancer properties came in 1995.
Two French researchers found that ivermectin (a Nobel Prize winning anti-parasite drug) could reverse multidrug resistance in tumors.
The drug targets tumor stem cells—a driver of cancer tumors and relapses—and promotes cancer death.

---

quote:

---

Mr. Alderson got started with 10 rounds of radiation therapy. Initially, his carcinoembryonic antigen (CEA), a marker for tumor activity, was significantly elevated at 480 nanograms per milliliter (ng/mL). A month later, he started chemotherapy. By then, his CEA levels had risen to 1,498 ng/mL.

By the time Mr. Alderson started treatment, his colon cancer had metastasized and spread to his liver, where he had 25 tumors. “I was off their charts,” Mr. Alderson said in an interview with The Cancer Box, a cancer diagnosis blog. Due to concerns about COVID-19 and the ongoing pandemic, Mr. Alderson started looking into preventative medication and found ivermectin. Further research showed that the drug could likely enhance the effectiveness of his chemotherapy and radiation therapy and was relatively safe. In February 2021, he began taking ivermectin. Ten days later, his CEA levels had dropped to 184 ng/mL.

. . .

Mr. Alderson went on to live another two years before succumbing to liver failure due to the progression of his three remaining liver tumors.

“His life was definitely extended,” Mrs. Alderson said, reflecting on Mr. Alderson’s cancer journey.

She attributes Mr. Alderson’s survival beyond his prognosis to his success with ivermectin and the chemotherapy drug fluorouracil. “Ivermectin was instrumental,” she said.

---